HealthShare ranks for 4th consecutive year in Deloitte Tecnology Fast 500™

HealthShare ranks for 4th consecutive year in Deloitte Tecnology Fast 500™

HealthShare has ranked in the Deloitte Technology Fast 500™ for Asia Pacific for the fourth consecutive year. The program celebrates innovation and recognises the fastest-growing public and private companies around the world.

“Overall, 90 Australian companies feature in the Tech Fast 500, the highest in the last 13 years and third only to China (119) and Taiwan (101) – who have almost doubled their number of entries since 2016”, Deloitte reported. “Australian companies feature strongly at the top, making up to 30% of the top twenty growth companies.”

HealthShare’s CEO, Rami Wiess is proud of the work HealthShare is dong to improve health outcomes for all Australians. “Everything we do at HealthShare is centred around enriching the health landscape, improving the quality of health information and increasing accessibility to healthcare providers for a fair and equitable health system”, he said. “This award is a great recognition for our team’s efforts and we look forward to continuing to build world-class digital health solutions”.

HealthShare won the Westpac 200 Businesses of Tomorrow Award in 2017, the Deloitte Technology Asia Pacific Fast 500™ Award in 2017, 2016, and 2015, and the Deloitte Technology Fast 50™ Rising Star Award in 2014.

Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK provate company limited by guarantee (“DTTL”), its network of member firms, and their related entities. DTTL and each of its member firms are legally separate and independent entities. DTTL (also referred to as “Deloitte Global”) does not provide services to clients. Please see to learn more about their global network of member firms.

Related articles

COVID ‘bump’ on the way?

While COVID has disrupted many regular seasonal trends, we've taken a look at procedure search trends across the Top 12 procedures searched

Macquarie Neurosurgery Webinar – CSF Disorders and Brain Tumours

Recently, HealthShare partnered with Macquarie Neurosurgery to host a webinar for GPs focused on the latest advancements in the treatment

Easing of elective surgery restrictions sees 126% increase in PHI filter selection by GPs and Patients

With the initial easing of elective surgery restrictions and so many Australians being financially impacted since the introduction of COVID-